Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?
about
Pharmacologic therapy for inflammatory bowel disease refractory to steroidsOptimization of the treatment with immunosuppressants and biologics in inflammatory bowel diseaseDifferential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesVaccines and recommendations for their use in inflammatory bowel disease.First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?Advances in the medical management of paediatric IBD.Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered Care.
P2860
Q26796415-9D9E7561-A257-40E3-867C-5EDA4ADF2C1BQ26866940-A1663341-E8BE-4BF8-AABC-1D5BA9ADF68DQ28085134-87E4FF40-588D-4A28-B910-361DABB7D648Q36699251-CD3388B6-3D02-4D45-B875-879B7A893568Q38086355-7A505D9D-0AD9-4703-B337-00B02425ECD0Q38130044-AD5CC663-528E-47BD-9FB4-73548CAD9A68Q46761838-7CA0CDB0-0178-422B-856E-99D6BCF8CBADQ48056630-D0B2470B-4B26-4B0E-8DAE-1B1A674B0CE3
P2860
Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?
@en
type
label
Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?
@en
prefLabel
Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?
@en
P2860
P356
P1433
P1476
Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?
@en
P2860
P304
P356
10.1159/000338144
P577
2012-07-12T00:00:00Z